Daniel Gillett, n/a

Cambridge University Hospitals NHS Foundation Trust
N/A, United Kingdom

Disclosure information not submitted.

Presentation(s):

• MON-022 - Osilodrostat Therapy and 11C-Methionine PET to Improve Corticotroph Pituitary Adenoma Detection and Localisation in Patients with Cushing Disease (OPTIMAL); Study Design and Rationale

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT